Hirotoshi Akiyama

Summary

Country: Japan

Publications

  1. ncbi Biliobiliary fistulas manifested by worsening liver function--a case report
    Takashi Ishikawa
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Kobayashi Clinic, Yokohama, Japan
    Hepatogastroenterology 52:1092-4. 2005
  2. doi Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
    J Chemother 24:364-8. 2012
  3. doi Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    Cancer Chemother Pharmacol 67:1363-8. 2011
  4. ncbi Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
    Takashi Kosaka
    Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Cancer Chemother Pharmacol 73:281-5. 2014
  5. ncbi Therapeutic strategy for patients with pN0 gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
    J Surg Oncol 94:212-9. 2006
  6. ncbi Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Anticancer Res 33:697-704. 2013
  7. ncbi Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy
    Tomoko Wada
    Department of Surgery, Gastroenterological Center, Yokohama City University, Minami Ku, Yokohama, Japan
    Anticancer Res 33:1747-51. 2013
  8. ncbi Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Japan
    Oncology 83:183-91. 2012
  9. ncbi Impact of palliative gastrectomy in patients with incurable advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Minami Ku, Yokohama, Japan
    Anticancer Res 28:1309-15. 2008
  10. doi Application of the transorally inserted anvil (OrVil) after laparoscopy-assisted total gastrectomy
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafunecho, Minami Ku, Yokohama 232 0024, Japan
    Surg Endosc 25:1300-5. 2011

Collaborators

Detail Information

Publications72

  1. ncbi Biliobiliary fistulas manifested by worsening liver function--a case report
    Takashi Ishikawa
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Kobayashi Clinic, Yokohama, Japan
    Hepatogastroenterology 52:1092-4. 2005
    ....
  2. doi Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
    J Chemother 24:364-8. 2012
    ..The recommended dose (RD) of DOC was therefore defined as 25 mg/m². There is a need for a phase II clinical trial using this regimen in patients with S-1-refractory stage II/III gastric cancer...
  3. doi Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    Cancer Chemother Pharmacol 67:1363-8. 2011
    ..We evaluated the efficacy and toxicity of biweekly S-1 and docetaxel combination therapy in patients with advanced gastric cancer...
  4. ncbi Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
    Takashi Kosaka
    Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Cancer Chemother Pharmacol 73:281-5. 2014
    ..This study was held to evaluate the efficacy and safety of DS followed by surgery...
  5. ncbi Therapeutic strategy for patients with pN0 gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
    J Surg Oncol 94:212-9. 2006
    ..The prognosis for patients with pN0 gastric cancer is moderately hopeful (expected 5-year survival: 80%). However, the relevant prognostic factors and most appropriate surveillance protocol have not been identified...
  6. ncbi Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Anticancer Res 33:697-704. 2013
    ..This study assessed the toxicity and activity of biweekly docetaxel and S-1 combination therapy in elderly patients with advanced gastric cancer...
  7. ncbi Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy
    Tomoko Wada
    Department of Surgery, Gastroenterological Center, Yokohama City University, Minami Ku, Yokohama, Japan
    Anticancer Res 33:1747-51. 2013
    ..The objective of this study was to clarify the risk factors for recurrence in patients who received S-1 adjuvant chemotherapy...
  8. ncbi Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Japan
    Oncology 83:183-91. 2012
    ..This study was conducted to determine the prognostic value of the Glasgow Prognostic Score (GPS), an inflammation-based prognostic score composed of C-reactive protein and albumin, for patients with advanced cancer...
  9. ncbi Impact of palliative gastrectomy in patients with incurable advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Minami Ku, Yokohama, Japan
    Anticancer Res 28:1309-15. 2008
    ..The efficacy of palliative gastrectomy for incurable advanced gastric cancer remains debatable...
  10. doi Application of the transorally inserted anvil (OrVil) after laparoscopy-assisted total gastrectomy
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafunecho, Minami Ku, Yokohama 232 0024, Japan
    Surg Endosc 25:1300-5. 2011
    ..In this study, we compared the short-term outcomes of LATG reconstructed by mini-laparotomy and by the newly developed transorally inserted anvil (OrVil)...
  11. doi Tumor diameter as a prognostic factor in patients with gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Ann Surg Oncol 15:1959-67. 2008
    ..The aim of this study was to evaluate the prognostic value of tumor diameter in gastric cancer...
  12. doi Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: a case-control study
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Surg Endosc 26:804-10. 2012
    ..The aim of this study was to clarify the technical feasibility and oncological efficacy of laparoscopy-assisted gastrectomy (LAG) for gastric cancer compared with open gastrectomy (OG)...
  13. ncbi Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Ann Surg Oncol 13:659-67. 2006
    ..The surgical results of D2 and D3 gastrectomy (para-aortic lymph node dissection) were retrospectively compared...
  14. ncbi Significance of long-term follow-up of early gastric cancer
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    Ann Surg Oncol 13:363-9. 2006
    ..Improvements in therapeutic outcomes are being sought by studying the timing and causes of death. Here, the results of surgery were evaluated to assess the appropriate treatment and follow-up schedule for early gastric cancer...
  15. ncbi Appropriate routes of reconstruction following transthoracic esophagectomy
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Minami Ku, Yokohama, 232 0024, Japan
    Hepatogastroenterology 54:1997-2002. 2007
    ..The effectiveness of reconstructive methods after esophagectomy remains controversial...
  16. ncbi Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    J Gastrointest Surg 12:802-10. 2008
    ..Randomized controlled trials should be used to develop effective modalities for each recurrence pattern to improve therapeutic outcomes...
  17. ncbi Clinicopathological features of gastric carcinoma in younger and middle-aged patients: a comparative study
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
    J Gastrointest Surg 10:1023-32. 2006
    ....
  18. doi Impact of lymphovascular invasion in patients with stage I gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
    Surgery 147:204-11. 2010
    ..Patients with stage I gastric cancer often suffer from tumor recurrence despite a generally favorable operative outcome. It is therefore important to determine the prognostic factors in order to improve such outcomes...
  19. doi Significance of thoracoscopy-assisted surgery with a minithoracotomy and hand-assisted laparoscopic surgery for esophageal cancer: the experience of a single surgeon
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    J Gastrointest Surg 15:1939-51. 2011
    ..This retrospective study evaluated the surgical learning curve and outcomes of thoracolaparoscopic esophagectomy...
  20. ncbi Comparison of results of surgery in the upper third and more distal stomach
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    J Gastrointest Surg 10:718-26. 2006
    ..Treatments for T2 or deeper and pN1 tumors in the upper third of the stomach, particularly for hematogenous metastasis, require further investigation...
  21. ncbi Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9 Fukuura, Kanazawa ku Yokohama 236 0004, Japan
    Hepatogastroenterology 53:473-8. 2006
    ..To clarify the efficacy of therapeutic continuous hyperthermic peritoneal perfusion in peritoneal carcinomatosis of gastric cancer...
  22. ncbi Effect of obesity on laparoscopy-assisted distal gastrectomy compared with open distal gastrectomy for gastric cancer
    Hirochika Makino
    Department of Surgery, Yokohama City University, Gastroenterological Center, Minami Ku, Yokohama, Japan
    J Surg Oncol 102:141-7. 2010
    ..This study compared surgical outcomes between patients undergoing laparoscopy-assisted distal gastrectomy (LADG) and those undergoing open distal gastrectomy (ODG) from the viewpoint of obesity...
  23. ncbi Predictive factors for pancreatic fistula after pancreaticosplenectomy for advanced gastric cancer in the upper third of the stomach
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Japan
    J Gastrointest Surg 10:132-7. 2006
    ..If this operative procedure must be used (e.g., in patients with extensive tumor presence), careful manipulation and appropriate drainage are essential, particularly in cases showing predictive factors of pancreatic fistula...
  24. ncbi Learning curve for laparoscopy-assisted distal gastrectomy with regional lymph node dissection for early gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Urafunecho, Minami Ku, Yokohama, Japan
    Surg Laparosc Endosc Percutan Tech 18:236-41. 2008
    ..LADG is a technically feasible surgical procedure, depending on the surgeon's technical proficiency. Experience of at least 60 cases of LADG seems to result in satisfactory patient outcomes...
  25. ncbi Lymph node status in patients with submucosal gastric cancer
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Ann Surg Oncol 13:1364-71. 2006
    ..The aim of this study was to clarify the lymph node status in patients with submucosal gastric cancer...
  26. ncbi The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9, Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Am J Surg 196:358-63. 2008
    ..The aim of this study was to determine the influence of stage migration on the outcomes of D2 gastrectomy compared with D3 gastrectomy in advanced gastric cancer...
  27. ncbi Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    Surgery 137:165-71. 2005
    ..Here we attempt to clarify the debate by retrospectively evaluating surgical outcome...
  28. ncbi Indication for hepatic resection in the treatment of liver metastasis from gastric cancer
    Hirochika Makino
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Anticancer Res 30:2367-76. 2010
    ..The significance of hepatic resection for liver metastasis after gastric cancer is not well established. This study aimed to evaluate the effect of hepatic resection in such patients...
  29. ncbi Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    Hepatogastroenterology 53:366-71. 2006
    ..It is important to clarify the predictive and prognostic factors for chemoradiotherapy (CRT) in patients with inoperable esophageal cancer...
  30. ncbi Phase I study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    Anticancer Res 28:2473-8. 2008
    ..Docetaxel and S-1 are novel antitumour chemotherapeutic agents with distinct toxicities. Here a phase I study of combined docetaxel and S-1 therapy for advanced gastric cancer is reported...
  31. ncbi Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9, Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Ann Surg Oncol 13:836-42. 2006
    ..The clinicopathologic characteristics of mucinous gastric carcinoma (MGC), an uncommon subtype of gastric carcinoma, were examined by comparing 45 MGC and 1255 non-MGC (NGC) cases...
  32. ncbi Surgical outcomes in patients with T4 gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    J Am Coll Surg 202:223-30. 2006
    ..There is controversy about the best therapeutic surgical approach for treatment of patients with T4 gastric cancer...
  33. ncbi Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus
    Ryo Takagawa
    Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama 236 0004, Japan
    Dis Esophagus 22:482-9. 2009
    ..These findings confirmed that the chemoradiotherapy regimen had curative potential for unresectable esophageal cancer...
  34. doi Therapeutic strategy for esophageal cancer based on solitary lymph node metastasis
    Chikara Kunisaki
    Department of Surgery, Yokohama City University, Yokohama, Japan
    Hepatogastroenterology 58:1561-5. 2011
    ..It is essential to perform appropriate lymph node dissection in esophageal cancer. However, it may be beneficial if lymph node dissection could be minimized to reduce the surgical stress...
  35. doi Impact of lymph-node metastasis site in patients with thoracic esophageal cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    J Surg Oncol 101:36-42. 2010
    ..We retrospectively compared surgical outcomes between patients with intra-thoracic and extra-thoracic (cervical and abdominal) lymph-node metastasis...
  36. doi Efficacy of laparoscopy-assisted distal gastrectomy for gastric cancer in the elderly
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57 Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Surg Endosc 23:377-83. 2009
    ..This study retrospectively compared surgical outcomes between elderly and nonelderly patients with gastric cancer...
  37. ncbi Clinicopathological properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Japan
    Anticancer Res 26:639-46. 2006
    ..The purpose of this study was to clarify the clinicopathological and biological properties of the poorly-differentiated types of gastric carcinoma (solid-type and non-solid-type)...
  38. ncbi Predictive factors for surgical complications of laparoscopy-assisted distal gastrectomy for gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Surg Endosc 23:2085-93. 2009
    ..To determine the predictive factors for the surgical complications of laparoscopic gastric surgery, surgical outcomes were evaluated...
  39. ncbi Clinical significance of the metastatic lymph-node ratio in early gastric cancer
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University Graduate School of Medicine, 4 57 Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    J Gastrointest Surg 12:542-9. 2008
    ..The metastatic lymph-node ratio may be a superior method of classification, which provides also accurate prognostic stratification for early gastric cancer patients...
  40. ncbi Surgical outcome of serosa-negative advanced gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
    Anticancer Res 24:3169-75. 2004
    ..Prophylactic therapeutic strategy should be advised for patients with many metastatic lymph nodes, for peritoneal or lymphatic recurrence and in patients with "medullary" stroma for hematogenous recurrence...
  41. ncbi Surgical outcomes for early gastric cancer in the upper third of the stomach
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0024, Japan
    J Am Coll Surg 200:15-9. 2005
    ..The aim of this study is to analyze and establish a therapeutic strategy for early tumors in the upper third of the stomach...
  42. ncbi Clinical impact of metastatic lymph node ratio in advanced gastric cancer
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Fukuura Kanazawa ku, Yokohama 236 0004, Japan
    Anticancer Res 25:1369-75. 2005
    ..We examined the prognostic value of metastatic lymph node ratio (the ratio of the number of metastatic lymph nodes to the number of lymph nodes removed) after curative resection...
  43. ncbi Relevance of reduced-port laparoscopic distal gastrectomy for gastric cancer: a pilot study
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan
    Dig Surg 29:261-8. 2012
    ....
  44. doi A pilot study comparing jejunal pouch and jejunal interposition reconstruction after proximal gastrectomy
    Ryo Takagawa
    Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
    Dig Surg 27:502-8. 2010
    ..We therefore conducted a prospective pilot study comparing reconstructions using jejunal pouch interposition or jejunal interposition...
  45. ncbi Therapeutic strategy for scirrhous type gastric cancer
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine 3 9 Fukuura Kanazawa ku, Yokohama, Japan
    Hepatogastroenterology 52:314-8. 2005
    ..As no appropriate therapeutic strategy has yet been established in scirrhous type gastric cancer, we retrospectively analyzed the therapeutic outcomes in patients with this type of cancer...
  46. ncbi Surgical outcome in superficially spreading early gastric cancer
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236 0004, Japan
    Oncology 68:52-7. 2005
    ..Superficially spreading early gastric cancer is characterized by wide horizontal extension without deep vertical invasion. This study aimed to clarify the clinicopathological characteristics and prognosis of this rare disease...
  47. ncbi Yearly alterations in prognostic factors in gastric cancer during the post-operative period
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan
    Anticancer Res 24:377-83. 2004
    ..Ascertaining prognostic factors appropriate for each post-operative year should contribute to the establishment of better therapeutic strategies and ultimately to the improvement of their long-term results...
  48. ncbi High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence
    Ryo Takagawa
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    Ann Surg Oncol 17:81-8. 2010
    ..This study aimed to clarify the relationship between aPKClambda/iota expression and the clinicopathological features of gastric cancer...
  49. ncbi Modified POSSUM to predict postoperative morbidity following gastrectomy
    Yuichi Otsuka
    Gastroenterological Surgery, Yokohama City University, Japan
    Hepatogastroenterology 54:1142-5. 2007
    ..In order to predict morbidity after gastrectomy for gastric cancer in aged patients, the Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) scoring system was applied...
  50. ncbi Surgical outcome of para-aortic lymph node dissection preserving neural tissue based on anatomical evaluations
    Masato Nomura
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanazawa Ku, Yokohama, Japan
    J Gastrointest Surg 9:781-8. 2005
    ..7 and 9.7 months, respectively (P < 0.02). We conclude that para-aortic lymph node dissection preserving neural tissue is useful in patients with three or fewer para-aortic metastatic lymph nodes that are in front of the neural tissue...
  51. ncbi Prospective randomized controlled trial comparing the use of 3.5-mm and 4.8-mm staples in gastric surgery
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Hepatogastroenterology 55:1943-7. 2008
    ..The purpose of this study was to evaluate and compare the use of 4.8-mm and 3.8-mm staples in gastric resection...
  52. ncbi Outcomes of mass screening for gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, 3 9 Fukuura Kanazawaku, Yokohama 236 0004, Japan
    Ann Surg Oncol 13:221-8. 2006
    ..The objective of our study was to assess the efficacy of mass screening for gastric cancer by using a barium meal...
  53. ncbi Implication of extended lymph node dissection stratified for advanced gastric cancer
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Anticancer Res 23:4181-6. 2003
    ..What extent of lymph node dissection for advanced gastric cancer is appropriate is a matter of controversy...
  54. ncbi Developing an appropriate staging system for esophageal carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    J Am Coll Surg 201:884-90. 2005
    ..In this study, we evaluated the surgical outcomes of esophageal cancer according to five existing staging systems and assessed their prognostic significance...
  55. ncbi Distribution of lymph node metastasis in gastric carcinoma
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9, Fukuura Kanazawa ku, Yokohama, 236 0004, Japan
    Hepatogastroenterology 53:468-72. 2006
    ..In gastric cancer, appropriate lymph node dissection increases survival, and hence it is of value to determine lymph node metastasis distribution in the early phase of progression...
  56. ncbi Comparative evaluation of gastric carcinoma staging: Japanese classification versus new american joint committee on cancer/international union against cancer classification
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan
    Ann Surg Oncol 11:203-6. 2004
    ..This study was designed to compare these staging systems and devise a more rational system for gastric carcinoma...
  57. ncbi Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients
    Chikara Kunisaki
    Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Am J Surg 191:216-24. 2006
    ..We compared clinicopathological features and results of surgery for gastric carcinoma in elderly and middle-aged patients to develop appropriate treatment for elderly patients with gastric carcinoma...
  58. ncbi Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
    Anticancer Res 25:2973-7. 2005
    ..We conducted a pilot phase II study to evaluate the efficacy and safety of docetaxel and cisplatin as a combination second-line therapy for advanced gastric cancer...
  59. doi Clinical characteristics of rectal cancer involving the anal canal
    Mitsuyoshi Ota
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    J Gastrointest Surg 15:460-5. 2011
    ..This study evaluates the clinical characteristics of rectal cancer involving the anal canal...
  60. ncbi Adjuvant hepatic arterial infusion chemotherapy with 5-Fluorouracil and interferon after curative resection of hepatocellular carcinoma: a preliminary report
    Takafumi Kumamoto
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    Anticancer Res 33:5585-90. 2013
    ..The aim of the present study was to evaluate the efficacy of adjuvant hepatic arterial infusion chemotherapy with 5-fluorouracil (5-FU) and systemic interferon (IFN)...
  61. ncbi Assessment of gastric emptying function after gastrectomy using a real-time ¹³C breath test
    Yuki Homma
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    Hepatogastroenterology 59:2335-8. 2012
    ..We assessed post-PPG gastric emptying with a continuous real-time ¹³C breath test (BreathID system, Oridion, Israel)...
  62. pmc Effect of obesity on intraoperative bleeding volume in open gastrectomy with D2 lymph-node dissection for gastric cancer
    Hirochika Makino
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Patient Saf Surg 2:7. 2008
    ..To investigate the effect of obesity on open gastrectomy with D2 lymph-node dissection...
  63. ncbi Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer
    Goro Matsuda
    Department of Surgery, Gastroenterological Center, Graduate School of Medicine, Yokohama City University, Japan
    Anticancer Res 29:2863-7. 2009
    ..We retrospectively evaluated the efficacy of weekly paclitaxel therapy as second-line treatment for patients with advanced gastric cancer that was refractory to S-1...
  64. ncbi Video-assisted thoracoscopic esophagectomy with a voice-controlled robot: the AESOP system
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, School of Medicine, Japan
    Surg Laparosc Endosc Percutan Tech 14:323-7. 2004
    ..Laparoscopic and thoracoscopic surgery with the AESOP system has the potential to enable a single surgeon to perform a complex surgical procedure like esophagectomy...
  65. pmc Major liver resection stimulates stromal recruitment and metastasis compared with repeated minor resection
    Masashi Momiyama
    AntiCancer, Incorporated, San Diego, California, USA
    J Surg Res 178:280-7. 2012
    ..The present study examined the effects of types of liver resection on the growth of liver and lung metastases...
  66. ncbi Impact of splenectomy in patients with gastric adenocarcinoma of the cardia
    Chikara Kunisaki
    Department of Surgery, Gastroenterological Center, Yokohama City University, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    J Gastrointest Surg 11:1039-44. 2007
    ..Splenectomy should be limited in those patients with gastric cardia tumors invading the spleen or with metastatic bulky lymph nodes extending to the spleen...
  67. ncbi Immunonutrition risk factors of respiratory complications after esophagectomy
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan
    Nutrition 20:364-7. 2004
    ..There are many reports suggesting predictive factors for respiratory complications after esophagectomy, but few studies have focused on this problem from the aspect of immunonutrition...
  68. ncbi Prognostic factors in esophageal cancer
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan
    Hepatogastroenterology 51:736-40. 2004
    ..This paper deals with the prognostic factors in esophageal cancer after potentially curative resection. Furthermore, correlation of the genetic alteration obtained from biopsy specimens with the prognostic factor was determined...
  69. ncbi Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University, School of Medicine, Yokohama, Japan
    Surgery 131:521-8. 2002
    ..Few studies have assessed the clinical significance of continuous hyperthermic peritoneal perfusion in peritoneal recurrence...
  70. ncbi Lymph node dissection in surgical treatment for remnant stomach cancer
    Chikara Kunisaki
    Second Department of Surgery, Yokohama City University School of Medicine, 3 49, Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Hepatogastroenterology 49:580-4. 2002
    ..Lymphatic flow and the incidence of lymph node metastasis in remnant stomach cancer after distal gastrectomy are obscure. There is consequent controversy about appropriate lymph node dissection in such cases...
  71. pmc A giant adrenal pseudocyst presenting with right hypochondralgia and fever: a case report
    Masashi Momiyama
    Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan
    J Med Case Reports 5:135. 2011
    ..abstract:..
  72. ncbi Clinical evaluation of granisetron as an inhibitor of nausea and vomiting induced by oral anticancer drugs
    Shinji Togo
    Department of Surgery II, Yokohama City University, Kanazawa Ku, Yokohama 236 0004, Japan
    Oncol Rep 9:277-82. 2002
    ..2% on the 5th day of treatment. iv) There was no adverse reaction or abnormality of laboratory test values attributable to granisetron. Granisetron was safe and effective against nausea and vomiting induced by oral anticancer drugs...